Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML).

Fridle, Chantal; Medinger, Michael; Wilk, Matthias C; Seipel, Katja; Passweg, Jakob; Manz, Markus G; Pabst, Thomas (2017). Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML). Leukemia & lymphoma, 58(5), pp. 1068-1075. Informa Healthcare 10.1080/10428194.2016.1235274

[img] Text
Fridle et al.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (990kB) | Request a copy

BACKGROUND The prognosis for relapsing AML patients is disappointing and the preferred salvage chemotherapy is unclear. Among other regimens, cladribine, cytarabine, and idarubicin (CLA-Ida) is used. METHODS We analyzed relapsing AML patients receiving CLA-Ida chemotherapy between July 2012 and April 2015 at three academic centers in Switzerland. RESULTS Thirty-four patients underwent at least one cycle of CLA-Ida chemotherapy, with 6 patients having two cycles. Treatment-related mortality was 5.9% (2/34 patients). Eighteen patients (52.9%) achieved a complete remission (CR2), and 16 (47.1%) received subsequent allogeneic transplantation, with 8 (23.5%) of these patients remaining in complete remission after a median follow-up of 6 months. In contrast, all 16 patients not achieving CR2 died within 12 months after relapse due to progressive disease. CONCLUSION Our data suggest a promising rate of complete remission following CLA-Ida salvage treatment in relapsing AML patients enabling a substantial proportion of such patients to proceed to allogeneic transplantation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Seipel, Katja and Pabst, Thomas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1042-8194

Publisher:

Informa Healthcare

Language:

English

Submitter:

Marianne Zahn

Date Deposited:

27 Dec 2016 14:36

Last Modified:

14 Sep 2017 16:02

Publisher DOI:

10.1080/10428194.2016.1235274

PubMed ID:

27735213

Uncontrolled Keywords:

AML; CLA-Ida; complete remission; overall survival; relapse

BORIS DOI:

10.7892/boris.92008

URI:

https://boris.unibe.ch/id/eprint/92008

Actions (login required)

Edit item Edit item
Provide Feedback